Clinical Trial Information Request for Protocol 24-217 Title Comeback from Long Course ADT with Relugolix and Darolutamide in Hormone-Sensitive Prostate Cancer (CLEARED) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone